Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity (original) (raw)
IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures
Robert Kastelein
Journal of Immunology, 1988
View PDFchevron_right
Effects of Interleukin 4 Upon Human Tumoricidal Cells Obtained From Patients Bearing Solid Tumors
John Yannelli
Journal of Leukocyte Biology, 1991
View PDFchevron_right
Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon α
Elisabeth Perez-ruiz
Cancer Immunology Immunotherapy, 1993
View PDFchevron_right
Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies
Alton Morgan
The Journal of Immunology
View PDFchevron_right
GM-CSF Augments the IL-4 Induced Cytotoxic Activity of Human Peripheral Blood Mononuclear Cells in the Presence of the Mouse Monoclonal Antibody 17–1A
Giuseppe Masucci
Molecular Oncology and Clinical Applications, 1993
View PDFchevron_right
Human recombinant interleukin-4 inhibits lymphokine-activated killer activity of sheep erythrocyte rosette-forming (E+) and -non-forming (E−) human lymphocytes
Massimo Gerosa
International Journal of Cancer, 1988
View PDFchevron_right
Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors
Eric Robinet
European Journal of Immunology, 1992
View PDFchevron_right
Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3 mAb
Michel Moutschen
Cancer Immunology Immunotherapy, 1996
View PDFchevron_right
Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2
Jacquelyn Hank
Cancer research, 1990
View PDFchevron_right
Murine monoclonal IgG3 to human colorectal tumor-associated antigens: enhancement of antibody-dependent cell-mediated cytotoxicity by interleukin 2
Alton Morgan
Cancer research, 1989
View PDFchevron_right
IL-1 and IL-4 as reciprocal regulators of IL-2 induced lymphocyte cytotoxicity
Sidney Golub
British journal of cancer, 1990
View PDFchevron_right
Induction of Nonspecific Cell-Mediated Cytotoxicity: A Multisignal Event and its Cellular Regulation
Christoph Bührer
2000
View PDFchevron_right
Studies on cytotoxicity generated in human mixed lymphocyte culture
Sidney Golub
Cancer Immunology Immunotherapy, 1988
View PDFchevron_right
Activation of human blood lymphocyte subsets for cytotoxic potential
Giuseppe Masucci
Cellular Immunology, 1982
View PDFchevron_right
Effect of interleukin-4 on interleukin-2-dependent generation of natural killer cells
Carlo Riccardi
Cellular Immunology, 1991
View PDFchevron_right
Generation of human lymphokine-activated killer cells following brief exposure to high dose interleukin 2
John Yannelli
Cancer research, 1990
View PDFchevron_right
Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay
Marita Troye-blomberg
Cancer Immunology Immunotherapy, 1983
View PDFchevron_right
Interleukins 2 and 12 Produce Significant Recovery of Cytotoxic Function in Dibutyltin-Exposed Human Natural Killer Cells
Bommanna Loganathan
Environmental Research, 2002
View PDFchevron_right
Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon ? and tumour necrosis factor ? treatment of tumour cells potentiates their interaction with autologous blood lymphocytes
Luis Carlos Rodriguez Alvarez
Cancer Immunology Immunotherapy, 1995
View PDFchevron_right
In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2
Jacquelyn Hank
Cancer research, 1988
View PDFchevron_right
Stimulation and proliferation of CD4+ peripheral blood T lymphocytes induced by an anti-CD4 monoclonal antibody
Giuseppe Tambussi
European Journal of Immunology, 1988
View PDFchevron_right
Enhancement by interleukin 4 of interleukin 2-or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients
Jonathan Treisman
Cancer research, 1990
View PDFchevron_right
Discrepancy between direct and antibody-dependent cytotoxic activities of human LAK cells
M. Potapnev
Immunology Letters, 1994
View PDFchevron_right
In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro
Marijke Bleumink
Cellular Immunology, 1991
View PDFchevron_right
Natural killing and antibody-dependent cellular cytotoxicity: Characterization of effector cells by E-rosetting and monoclonal antibodies
Nurul Aida
Cellular Immunology, 1983
View PDFchevron_right
Antineoplastic effects of interleukin-4
Pablo Leon
Journal of Surgical Research, 1992
View PDFchevron_right
Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors
U. Sahin
Cancer Immunology, Immunotherapy, 1996
View PDFchevron_right
Natural killer activity of human blood lymphocytes
Maria Masucci
Molecular Immunology, 1982
View PDFchevron_right